Type 2 diabetes management Flashcards
If someones A1C is 1.5% above target what do you start
Metformin plus a second agent
What is first line therapy if healthy behaviour interventions don’t work?
Metformin
If someone presents with symptomatic hyperglycemia and/or metabolic decompensation, what do you start?
What symptoms do you look for?
Symptoms
- Polyuria (pee a lot)
- Polydipsia (thirst)
- Weight loss
- Volume depletion
Start insulin +/- metformin
What is the starting dose for metformin? Titrate? MDD?
Adjust in CKD?
250mg once daily titrated q3-7 days.
Max daily dose 2550mg/day
How do you adjust metformin dose based on kidney function?
eGFR 45+ = no dose adjustment
eGFR under 45 = decrease dose
eGFR under 30 = DO NOT USE
What are common or serious ADRs of metformin
- GI N/V/D
- Metallic taste
- Lactic acidosis
How much does metformin lower A1C by?
1-1.5%
What is lactic acidosis?
Which type of patients is it most commonly seen in?
Metformin accumulation
- metformin shuts down enzyme that converts lactate to pyruvate
- impaired gluconeogenesis
Most common in
- renal insufficiency
- liver disease (excessive alcohol)
- cardiac failure
Which is the best agent in lowering A1C effect when added to merformin?
- SC semaglutide and other GLP1 receptor agonists
Which agent has the highest hypoglycemic risk in addition to metformin
Premixed insulin
Which SGLT2 inhibitor should be taken before the first meal of the day?
Canaglifozin
What is the expectation of eGFR when you start an SGLT2i
eGFR will drop a bit
What should you monitor for pre-treatment assessment when starting SGLT2i
Renal function
- Do not start if eGFR under 20
- Volume status including BP and electrolytes (correct first)
- Signs of decreased BP
- Assess for risk of amputation, fracture, DKA
What are ADRs of GLP-1 receptor agonists? Hypo risk? Contraindications? ongoing monitoring what value?
- GI side effects N/V/D
- Acute pancreatitis
- Risk of thyroid c-cell tumours
Low hypo risk
CI: family history of medullary thyroid cancer and multiple neoplasia syndrome type 2
Monitor: SCr
Which DPP4 does not need renal dose adjustment
Linagliptin (trajenta)